Bismuth-cyclized cell-penetrating peptides showed improved cellular entry and metabolic stability compared to linear peptides, avoiding the epimerization problems of previous cyclization methods.
No epimerizationBismuth cyclization avoids the amino acid scrambling (epimerization) that plagued previous peptide cyclization methods
What the researchers found
Bismuth-cyclized cell-penetrating peptides showed improved cellular entry efficiency and metabolic stability compared to linear CPPs, without the epimerization issues of previous cyclization methods.
Why it matters
Getting drugs and research tools inside cells is a major challenge in medicine. Better cell-penetrating peptides could improve drug delivery for many conditions, from cancer to genetic diseases.
The numbers in context
Not specified — this is a proof-of-concept study demonstrating the bismuth cyclization method.
How the study worked
Laboratory development and testing of a novel peptide cyclization method using bismuth coordination chemistry.
Who was studied
In vitro cell culture experiments
What this study cannot tell us
This is an early-stage laboratory study. The bismuth-cyclized peptides need to be tested in living organisms to confirm safety and effectiveness.
How to read the evidence
Rated preliminary: proof-of-concept chemistry study demonstrating the method. Biological applications need further validation.
When this study was published
Published in 2024. Novel chemistry approach with potential broad applications in peptide drug delivery.
The bigger picture
Cell-penetrating peptides are a key technology for drug delivery, but linear peptides break down quickly. Better cyclization methods that improve stability without technical drawbacks advance the entire drug delivery field.
Questions still open
- Is bismuth biocompatible for in vivo use?
- Can this method be applied to therapeutic peptide cargoes?
Common questions
Why cyclize cell-penetrating peptides?
What is bismuth cyclization?
Read the original research
Bismuth-Cyclized Cell-Penetrating Peptides.
Molecular pharmaceutics, 21(10), 5255-5260
Citation
Ritchey, Jeremy L; Filippi, Lindsi; Ballard, Davis; Pei, Dehua. (2024). Bismuth-Cyclized Cell-Penetrating Peptides.. Molecular pharmaceutics, 21(10), 5255-5260. https://doi.org/10.1021/acs.molpharmaceut.4c00688